Faculty: Jeffrey A. Sosman, MD
Last Modified: February 5, 2014
Metastatic melanoma is a devastating cancer that has very few effective treatment options. New directions for the treatment of metastatic melanoma include targeted therapies that capitalize on the growing understanding of the genetic and molecular features of the disease. In addition, care of patients with advanced disease can benefit from improved assessment of patient response and better communication between healthcare providers. Continuing medical education is the ideal platform for communicating the evolving understanding of novel therapies and new treatment approaches for patients with metastatic melanoma. This educational activity is designed to meet the needs of oncologists, oncology nurses and other healthcare professionals who treat patients with melanoma. Upon completion of this educational activity, the participant should be able to:
Aug 18, 2014 - Poorly educated adults who smoke face a higher stroke risk, as do those who smoke and have hypertension, according to a study published online Aug. 14 in Stroke.
Aug 18, 2014
Dec 26, 2012
Jun 9, 2011
Aug 30, 2014